Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trialEngstrøm T, Kelbæk H, DANAMI-3—PRIMULTI Investigators et al. -
Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trialGershlick AH, Khan JN, Kelly DJ et al.
-
Balloon-to-door time: emerging evidence for shortening hospital stay after primary PCI for STEMIResnic FS, Shah SP
-
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trialLopes RD, Vora AN, Liaw D et al.
-
Myocardial Infarction in Young WomenVaccarino V.
-
Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary SyndromeKK Lee, AV Ferry, the High-STEACS Investigators.
-
Culprit versus multivessel coronary intervention in ST-segment elevation myocardial infarction: a meta-analysis of randomized trialsVaidya SR1, Qamar A, Arora S et al.
-
Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery diseaseAndersson HB, Pedersen F, Engstrøm T et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
